conv.

All stories
AIActive · 13h

Basecamp Research raises $140M Series C at $800M valuation, backed by Anthropic, Nvidia

The London AI-drug startup will use the funding to train new EDEN biology models and push in vivo cell therapies toward clinical development.

newest coverage 13h agosummary written 12h ago9 pieces NewswiresX

What to know

  • Basecamp Research's $140M Series C, led by S32 with Nvidia and new investor Anthropic participating, brings total funding to $225M and values the company at $800M, per Reuters.
  • The company trains biological foundation models (EDEN) on a proprietary genomic dataset from partnerships in over 30 countries, aiming to design in vivo cell therapies that reprogram cells inside the body rather than outside it.
  • So far the approach has only lab and mouse results; CTO Philip Lorenz says biology poses a far larger data and complexity challenge for AI than language modeling did.
  • Basecamp disclosed a six-program pipeline and hired a former Biogen executive as Chief Business Officer to expand pharma partnerships as it moves toward clinical development.

“The biotechnology revolution that began fifty years ago transformed how we make medicines. Personalised, AI-designed therapeutics represent the next transformation of that journey.”

André Hoffmann, Vice-Chairman of Roche, investor · PRNewswire ↗ · Sep 22

Glen Gowers Co-founder and CEO of Basecamp ResearchOliver Vince Co-founder of Basecamp ResearchPhilip Lorenz CTO of Basecamp ResearchAndy Conrad General Partner at S32, new board memberAnthropic Investor via its Anthology FundNvidia Investor via NVentures

Basecamp Research raises $140M Series C at $800M valuation, backed by Anthropic, Nvidia
The Decoder

How it unfolded 2 developments, newest first · click a bar or a number to jump articles

Peak 8 pieces in one half hour at Today, 9 AM; 9 pieces over 14 hours (8 articles · 1 post) Today, 9:20 AM — 8 pieces · 7 articles · 1 post — Newswires 7, X 1Today, 9:50 AM — 1 piece · 1 article — Newswires 1Today, 10:20 AM — quietToday, 10:50 AM — quietToday, 11:20 AM — quietToday, 11:50 AM — quietToday, 12:20 PM — quietToday, 12:50 PM — quietToday, 1:20 PM — quietToday, 1:50 PM — quietToday, 2:20 PM — quietToday, 2:50 PM — quietToday, 3:20 PM — quietToday, 3:50 PM — quietToday, 4:20 PM — quietToday, 4:50 PM — quietToday, 5:20 PM — quietToday, 5:50 PM — quietToday, 6:20 PM — quietToday, 6:50 PM — quietToday, 7:20 PM — quietToday, 7:50 PM — quietToday, 8:20 PM — quietToday, 8:50 PM — quietToday, 9:20 PM — quietToday, 9:50 PM — quietToday, 10:20 PM — quietToday, 10:50 PM — quiet 12
12 PM4 PM8 PMnow · 11:20 PM ET
  1. 2

    CTO Philip Lorenz says biology is a harder AI problem than language

    In an interview with The Decoder, CTO Philip Lorenz said Basecamp needs orders of magnitude more biological data than exists today, and that despite pharma's heavy AI investment, evidence of higher clinical success rates remains scarce; Basecamp's results so far are limited to lab and mouse data.

    “Given the complexity of biology, we just need orders of magnitude more data.”
    — Philip Lorenz, Basecamp Research CTO
    1. 1 outlet Inside Basecamp Research, the AI startup turning evolution into training data

      first by The Decoder, 13h ago

  2. 1

    Basecamp unveils six-program therapeutics pipeline

    Endpoints News reported that alongside the funding announcement, Basecamp disclosed a six-program pipeline as a test of its AI platform, and the company appointed former Biogen executive Richard Pearce as Chief Business Officer to expand pharma partnerships.

    “We believe the future of medicine lies in reprogramming the body to repair itself. We design the models and the medicines to teach it how.”
    — Glen Gowers, Co-founder and CEO, Basecamp Research · source

    1. 1 outlet first by Endpoints News, 13h ago · read ↗

    • A UK startup has just raised $140m to design new medicines with AI. The London startup is founded by @glen_gowers and Oliver Vince, and just announced their $140m Series C led by S32, with NVIDIA and Anthropic joining as new investors as well. Basecamp Research is teaching AI to understand biolog...

      @sebjohnsonukX13h agoview on X ↗
  3. background

    Reuters reports $800 million post-money valuation — Reuters reported that the $140 million raise values Basecamp Research at $800 million.

  4. background

    Basecamp Research closes $140M Series C led by S32 — The oversubscribed round included Nvidia's NVentures, Anthropic's Anthology Fund, the NATO Innovation Fund, the UK's Sovereign AI Fund, Rockefeller, Catalio and other investors, taking total funding to $225 million; the company said it will use the money to train a new generation of its EDEN models and advance therapeutics toward clinical development.

  5. background

    Gowers and Vince found Basecamp Research after Arctic DNA expedition — Co-founders Glen Gowers and Oliver Vince, who met as undergraduates at Oxford, set up an off-grid DNA sequencing operation on Iceland's Vatnajökull ice cap in 2019, an expedition that led to founding the company (Tech.eu reports 2019; The Decoder cites 2020 as the founding year).

Also covered reported alongside — the timeline has no entry for these yet

  1. 4 outlets Basecamp Research Raises $140M to Advance AI-Designed Medicines

    first by Ventureburn, 13h ago · also SiliconANGLE, Pulse 2.0, Basecamp Research

    4 more headlines

and 1 smaller piece